Global Exosomes Market Report 2024: The U.S. Market is Estimated at $245.9 Million, While China is Forecast to Grow at 11.7% CAGR
Exosomes Market
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Exosomes - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Exosomes estimated at US$801.1 Million in the year 2023, is projected to reach a revised size of US$2 Billion by 2030, growing at a CAGR of 12.4% over the analysis period 2023-2030.
Cancer Disease Indication, one of the segments analyzed in the report, is expected to record 14.2% CAGR and reach US$834 Million by the end of the analysis period. Growth in the Neurodegenerative Disease Indication segment is estimated at 11.8% CAGR for the next 8-year period.
The Exosomes market in the U.S. is estimated at US$245.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$344 Million by the year 2030 trailing a CAGR of 11.7% over the analysis period 2023 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 10.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.
The report features 45+ company profiles. Select companies featured include:
Danaher Corporation
Diagenode SA
FUJIFILM Holdings Corporation
Hitachi Chemical Co America Ltd.
Lonza Group Ltd.
MBL International Corporation
Miltenyi Biotec GmbH
Novus Biologicals LLC
QIAGEN GmbH
Thermo Fisher Scientific, Inc.
Key Attributes:
Report Attribute | Details |
No. of Pages | 196 |
Forecast Period | 2023 - 2030 |
Estimated Market Value (USD) in 2023 | $801.1 Million |
Forecasted Market Value (USD) by 2030 | $2000 Million |
Compound Annual Growth Rate | 12.4% |
Regions Covered | Global |
Key Topics Covered:
1. MARKET OVERVIEW
Influencer Market Insights
Exosomes - Global Key Competitors Percentage Market Share in 2022 (E)
Global Economic Update
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World 7-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 3: World Recent Past, Current & Future Analysis for Neurodegenerative diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 4: World 7-Year Perspective for Neurodegenerative diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 5: World Recent Past, Current & Future Analysis for Cardiovascular diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 6: World 7-Year Perspective for Cardiovascular diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Infectious diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World 7-Year Perspective for Infectious diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 9: World Exosomes Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
Table 10: World Recent Past, Current & Future Analysis for Exosomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 11: World 7-Year Perspective for Exosomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
Table 12: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 13: World 7-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 14: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 15: World 7-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 17: World 7-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/rxk8td
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
![](https://s.yimg.com/ny/api/res/1.2/uiyFNJOQrD2I7zS.ohUB5Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MA--/https://ml.globenewswire.com/media/ZmM4Y2ZkMjYtZjJmMC00YmQ3LTliYjktY2M5Yjk3ZDQ2ZWM4LTEwMjY3Mzc=/tiny/Research-and-Markets.png)